De-Wei Lai | Microbiology | Best Scholar Award

Posted on by ScienceFather

Prof. Dr. De-Wei Lai | Microbiology | Best Scholar Award

Associate Researcher at Taichung Veterans General Hospital, Taiwan

Dr. De-Wei Lai is an accomplished Associate Researcher at the Department of Medical Research, Taichung Veterans General Hospital, Taiwan. With a strong foundation in applied chemistry and immunology, he has dedicated his career to unraveling the complexities of regulatory T cells in diverse pathological conditions. Dr. Lai’s research spans autoimmunity, regenerative medicine, and the tumor microenvironment, with a focus on innovative immunotherapeutic strategies. His expertise integrates modern molecular techniques with natural extracts and traditional Chinese medicine, aiming to develop novel diagnostic and therapeutic solutions. With over 19 SCI/SCIE-indexed publications, 27 editorial appointments, and 16 awards, Dr. Lai has established himself as a leading voice in immunological research. His work, characterized by precision and translational potential, continues to shape the future of immunotherapy.

Professional Profile

Education

Dr. De-Wei Lai completed his undergraduate studies in Applied Chemistry at National Pingtung University, where he developed a deep interest in cellular metabolism and biochemical signaling pathways. He later pursued a Ph.D. in Immunology, focusing on the molecular mechanisms underlying diabetic retinopathy, which culminated in a groundbreaking publication in Circulation Research. His academic journey is marked by excellence in understanding complex immunological pathways and leveraging this knowledge for practical medical applications.

Professional Experience

Dr. Lai began his research career in 2019 at Chang Bing Show Chwan Memorial Hospital, where he studied the isolation, cultivation, and functional analysis of regulatory T cells (Tregs). His work laid the foundation for significant advancements in immunotherapy. In 2024, he joined Taichung Veterans General Hospital, where he expanded his focus to include molecular mechanisms of Tregs in autoimmune diseases, regenerative medicine, and tumor microenvironments. Throughout his career, Dr. Lai has consistently contributed to high-impact research, addressing critical gaps in clinical immunology and advancing innovative therapeutic strategies.

Research Interests

Dr. Lai’s research interests lie at the intersection of immunotherapy, molecular biology, and regenerative medicine. His laboratory explores the molecular mechanisms of regulatory T cells in autoimmune diseases, age-related degenerative conditions, and cancer. Recently, Dr. Lai has extended his work to study the potential of natural extracts, traditional Chinese medicine, and metal-organic nanoparticles as modulators of the immune system. By integrating experimental models with clinical big data, his research aims to develop novel diagnostic tools and immunotherapeutic strategies that address pressing medical challenges.

Research Skills

Dr. Lai possesses a robust skill set in immunological research and molecular biology. His expertise includes regulatory T cell isolation and expansion, animal model development for autoimmune diseases, and the study of tumor microenvironments. He is proficient in advanced techniques such as flow cytometry, immunohistochemistry, and molecular signaling analysis. His interdisciplinary approach also incorporates the evaluation of natural compounds and nanoparticles for therapeutic applications. With strong analytical skills and an eye for innovation, Dr. Lai excels in bridging basic research with translational medicine.

Awards and Honors

Dr. Lai’s contributions to immunological research have been widely recognized. He has received 16 awards and recognitions, highlighting his impact in both academic and clinical settings. These honors reflect his groundbreaking discoveries in T cell biology, innovative therapeutic approaches, and commitment to advancing immunotherapy. His editorial appointments in 27 journals and conferences further underscore his standing in the scientific community as a trusted authority in immunological research. Dr. Lai’s dedication to addressing clinical challenges continues to earn him accolades and inspire future research efforts.

Conclusion

Dr. De-Wei Lai is an excellent candidate for the Best Scholar Award due to his exceptional research achievements, dedication to addressing clinical challenges, and innovative approach to immunotherapy. While he excels in academic publication and editorial roles, areas like project leadership, patents, and international collaborations offer room for growth. Overall, his contributions to immunology and translational medicine make him a strong contender for this recognition.

Publications Top Notes

  • Melatonin set out to ER stress signaling thwarts epithelial mesenchymal transition and peritoneal dissemination via calpain‐mediated C/EBP β and NF κ B cleavage
    • Authors: SM Wu, WY Lin, CC Shen, HC Pan, W Keh‐Bin, YC Chen, YJ Jan, DW Lai, …
    • Journal: Journal of Pineal Research, 60 (2), 142-154
    • Year: 2016
    • Citations: 98
  • Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress, and inhibiting epithelial-to-mesenchymal transition
    • Authors: SH Liu, WJ Lee, DW Lai, SM Wu, CY Liu, HR Tien, CS Chiu, YC Peng, …
    • Journal: Molecular Oncology, 9 (4), 834-849
    • Year: 2015
    • Citations: 64
  • Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model
    • Authors: HC Pan, DW Lai, KH Lan, CC Shen, SM Wu, CS Chiu, KB Wang, …
    • Journal: Carcinogenesis, 34 (11), 2568-2579
    • Year: 2013
    • Citations: 45
  • Aryl hydrocarbon receptor deficiency attenuates oxidative stress-related mesangial cell activation and macrophage infiltration and extracellular matrix accumulation in diabetic nephropathy
    • Authors: WJ Lee, SH Liu, CK Chiang, SY Lin, KW Liang, CH Chen, HR Tien, …
    • Journal: Antioxidants & Redox Signaling, 24 (4), 217-231
    • Year: 2016
    • Citations: 44
  • The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination
    • Authors: DW Lai, SH Liu, AI Karlsson, WJ Lee, KB Wang, YC Chen, CC Shen, …
    • Journal: Oncotarget, 5 (17), 7788
    • Year: 2014
    • Citations: 43
  • Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways
    • Authors: CS Chiu, CH Tsai, MS Hsieh, SC Tsai, YJ Jan, WY Lin, DW Lai, SM Wu, …
    • Journal: Cancer Letters, 442, 113-125
    • Year: 2019
    • Citations: 42
  • TPL2 (therapeutic targeting tumor progression locus-2)/ATF4 (activating transcription factor-4)/SDF1α (chemokine stromal cell-derived factor-α) axis suppresses diabetic retinopathy
    • Authors: DW Lai, KH Lin, WHH Sheu, MR Lee, CY Chen, WJ Lee, YW Hung, …
    • Journal: Circulation Research, 121 (6), e37-e52
    • Year: 2017
    • Citations: 37
  • Attenuation of in vitro and in vivo melanin synthesis using a Chinese herbal medicine through the inhibition of tyrosinase activity
    • Authors: SC Liu, ML Sheu, YC Tsai, YC Lin, CW Chang, DW Lai
    • Journal: Phytomedicine, 95, 153876
    • Year: 2022
    • Citations: 22
  • Melatonin protects retinal integrity through mediated immune homeostasis in the sodium iodate-induced mouse model of age-related macular degeneration
    • Authors: LC Ku, ML Sheu, HH Cheng, CY Lee, YC Tsai, CY Tsai, KH Lin, LC Lai, …
    • Journal: Biomedicine & Pharmacotherapy, 161, 114476
    • Year: 2023
    • Citations: 10
  • AHR/TET2/NT5E axis downregulation is associated with the risk of systemic lupus erythematosus and its progression
    • Authors: HH Cheng, L Hung‐Ke, ML Sheu, CY Lee, YC Tsai, DW Lai
    • Journal: Immunology, 168 (4), 654-670
    • Year: 2023
    • Citations: 8

 

Francisco Boix Giner | Immunology and Microbiology | Best Researcher Award

Posted on by ScienceFather

Dr. Francisco Boix Giner | Immunology and Microbiology | Best Researcher Award

Clinical Immunologist, Blood Transfusion Center of the Valencian Community, Spain

Francisco José Boix Giner is a distinguished immunologist with a strong academic and professional background. Currently working at the Centro de Transfusión de la Comunidad Valenciana, he has a notable career in both clinical and research settings. Boix Giner’s expertise spans genomic characterization, immunogenetics, and biomarker validation, evidenced by his leadership in multiple research projects, including studies on leukemia, COVID-19, and organ transplantation. He earned his Ph.D. from the University of Murcia with a thesis on immunosuppressive treatment biomarkers. His professional experience includes roles at prestigious institutions such as the National Health Service Blood and Transplant and Anthony Nolan in the UK. With an h-index of 15 and substantial contributions to various research projects, Boix Giner’s work is highly regarded in the field of immunology. His research achievements reflect a deep commitment to advancing knowledge in immunogenetics and personalized medicine.

Profile

Education

Francisco José Boix Giner holds a comprehensive academic background in biomedical sciences. He earned his undergraduate degree in Biological Sciences with a specialization in Biomedicine from the University of Alicante in Spain, graduating with honors in September 2006. He further pursued advanced studies by completing a Master’s degree in Biomedical Technology and Research at the University of Murcia in September 2010, where he achieved an outstanding grade. Francisco then obtained his Ph.D. from the University of Murcia in June 2017, with a thesis focused on validating biomarkers for transplant patients undergoing immunosuppressive treatment. His doctoral work was conducted under the guidance of Manuel Muro Amador and Rocío Álvarez López, and it was awarded the highest distinction of “Sobresaliente Cum Laude.” This rigorous educational foundation has significantly contributed to his expertise and research in immunology and biomolecular sciences.

Professional Experience

Francisco José Boix Giner has accumulated extensive experience in immunology across several prestigious institutions. He currently serves as a Specialist in Immunology at the Centro de Transfusión de la Comunidad Valenciana, where he has been employed since November 2021. Previously, Boix held similar roles at the Hospital Universitario de Salamanca from June 2018 to November 2021, the National Health Service Blood and Transplant, and the Anthony Nolan Foundation in the UK, from 2013 to 2018. His career began at the Hospital Universitario Virgen de La Arrixaca, where he completed his residency in immunology. Boix’s work has involved leading and contributing to significant research projects, including genomic characterization of leukemia and studies on COVID-19 immunogenetics. His professional journey reflects a robust expertise in both clinical and research settings within the field of immunology.

Research Interest

Francisco José Boix Giner’s research interests center around immunology, with a particular focus on the genetic and molecular mechanisms underlying immune responses and transplant outcomes. His work includes characterizing genetic variations associated with immune system functions, such as the role of HLA and KIR genes in disease susceptibility and treatment responses. He has been involved in projects studying the impact of genetic markers on the resistance and relapse of leukemia, as well as the immunogenetic factors influencing COVID-19 prognosis. His research also extends to exploring biomarkers for assessing individual responses to immunosuppressive treatments in organ transplant patients. Boix Giner’s contributions aim to enhance the understanding of immune system interactions, improve diagnostic and therapeutic strategies, and advance personalized medicine in immunology and transplant science.

Research Skills

Francisco José Boix Giner possesses extensive research skills in the field of immunology and biomedicine. His expertise spans across various critical areas, including the characterization of genomic mechanisms in high-risk leukemia, the impact of HLA system on SARS-CoV-2 infections, and the identification of immune genetic variations in COVID-19 patients. Boix Giner has a proven track record in coordinating and leading significant research projects, such as those focused on biomarkers for preeclampsia and uterine growth restriction, as well as haplotypic characterization in leukemia patients. His proficiency in advanced techniques, including next-generation sequencing (NGS) and single-cell analysis, is complemented by his ability to secure and manage substantial research funding. His role in high-impact projects and collaborations with esteemed institutions highlights his skill in translating complex scientific data into actionable insights, furthering advancements in immunological research and patient care.

Award and Recognition

Francisco José Boix Giner, an esteemed immunologist, has garnered notable recognition in his field through a series of distinguished awards and accolades. He has been acknowledged for his significant contributions to the field of immunology, particularly in genomics and biomarker research. Boix Giner’s exceptional work has been recognized with multiple awards, including those for his innovative research on immune responses and transplantation. His research on the characterization of genomic mechanisms in leukemia and the validation of biomarkers in transplantation has earned him commendations from various institutions. In addition, he has received accolades for his leadership in high-impact research projects and his contributions to advancing understanding in immunogenetics and biomedicine. Boix Giner’s accolades underscore his commitment to scientific excellence and his influential role in the advancement of immunological research.

Conclusion

Francisco José Boix Giner is a well-qualified candidate for the Research for Best Researcher Award due to his extensive experience, significant contributions to immunology research, and strong academic background. To further strengthen his candidacy, focusing on increasing high-impact publications, expanding his research scope, and enhancing public engagement could be beneficial. Overall, his achievements and expertise make him a compelling candidate for the award.

Publication Top Notes

  1. Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study
    • Authors: Niño-Ramírez, J.E., Alcoceba, M., Gutiérrez-Zufiaurre, M.N., García-Sanz, R., Boix, F.
    • Year: 2024
    • Journal: HLA
  2. CD8+CD69+ and CD8+CD95+ Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients
    • Authors: Boix, F., Jimenez-Coll, V., Legaz, I., Llorente, S., Muro, M.
    • Year: 2023
    • Journal: Frontiers in Bioscience – Landmark
    • Citations: 1
  3. Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome
    • Authors: Jimenez-Coll, V., Llorente, S., Boix, F., Legaz, I., Muro, M.
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
    • Citations: 5
  4. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
    • Authors: Bailén, R., Alenda, R., Herruzo-Delgado, B., Anguita, J., Kwon, M.
    • Year: 2023
    • Journal: Frontiers in Immunology
    • Citations: 4
  5. Identification of the novel HLA-A*23:01:01:27 allele in an acute myeloid patient and related donor
    • Authors: Bastos, M., Alcoceba, M., Chillón, M.C., García-Sanz, R., Boix, F.
    • Year: 2022
    • Journal: HLA
    • Citations: 2
  6. The age again in the eye of the COVID-19 storm: evidence-based decision making
    • Authors: Martín, M.C., Jurado, A., Abad-Molina, C., Ocaña, E., Molina, J.
    • Year: 2021
    • Journal: Immunity and Ageing
    • Citations: 7
  7. The novel HLA-DQB1*06:03:27 allele characterised by sequence-based typing in a European bone marrow donor
    • Authors: Boix, F., Chillón, M.C., García-Sánchez, S., Alcoceba, M., Marín-Rubio, L.A.
    • Year: 2021
    • Journal: HLA
    • Citations: 2
  8. Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome
    • Authors: El Band, J.E.K., Llorente, S., Martinez-Garcia, P., Legaz, I., Muro, M.
    • Year: 2021
    • Journal: Current Protein and Peptide Science
    • Citations: 2
  9. Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain
    • Authors: Boix, F., Marín-Rubio, L.A., Alcoceba, M., González, M., García-Sanz, R.
    • Year: 2021
    • Journal: Human Immunology
    • Citations: 1
  10. Microrna expression changes in kidney transplant: Diagnostic efficacy of mir-150-5p as potential rejection biomarker, pilot study
    • Authors: Alfaro, R., Legaz, I., Jimenez-Coll, V., Llorente, S., Muro, M.
    • Year: 2021
    • Journal: Journal of Clinical Medicine
    • Citations: 14

 

 

Elena Prokopyeva | Immunology and Microbiology | Life Sciences Innovation Award

Posted on by ScienceFather

Dr. Elena Prokopyeva | Immunology and Microbiology | Life Sciences Innovation Award

Senior Researcher of Novosibirsk state university, Russia.

Elena Prokopyeva is a distinguished researcher and educator based at the Federal Research Center of Fundamental and Translational Medicine in Novosibirsk, Russia. Her academic journey began at Novosibirsk State University and progressed through advanced research positions at institutions like the FBRI State Research Center of Virology and Biotechnology ‘Vector’. Dr. Prokopyeva holds a PhD focused on the phenotypic and genotypic properties of influenza viruses and has made significant contributions to virology, studying various viruses including influenza, coronaviruses, and adenoviruses. Her expertise extends to virological methods, immunohistochemistry, and serological diagnostics. Dr. Prokopyeva has authored numerous high-impact publications, reflecting her extensive research in infectious diseases and cell biology. She is also a reviewer for MDPI and an expert for the Russian Science Foundation. Her achievements, coupled with her teaching roles in embryology and histology, underscore her valuable contributions to the scientific community.

Profile
Education

Elena Prokopyeva completed her undergraduate studies at Novosibirsk State University (NSU) from 2003 to 2009, where she specialized in Natural Science with a focus on Physiology. She pursued her graduate studies at the Institute of Molecular Biology and Biophysics, Siberian Branch of the Russian Academy of Medical Sciences, from 2009 to 2010, earning expertise in Biochemistry. Her research career began in earnest at the FBRI State Research Center of Virology and Biotechnology ‘Vector’, where she was a Researcher Graduate student from 2010 to 2013, focusing on Virology and Cell Biology. Prokopyeva earned her PhD in December 2015 from the same center, with a thesis on the phenotypic and genotypic properties of pandemic influenza A(H1N1)pdm09 virus. She has continued her academic and research activities at the Federal Research Center of Fundamental and Translational Medicine since 2013.

Professional Experience

Elena Prokopyeva has a distinguished career in virology and molecular biology, marked by extensive research and teaching roles. She began her academic journey at Novosibirsk State University, where she pursued undergraduate studies in natural science and later advanced her education with a PhD at the State Research Center of Virology and Biotechnology ‘Vector’. Her professional experience includes significant roles as a researcher at the Federal Research Center of Fundamental and Translational Medicine (FRC FTM) and as a lecturer in “Embryology,” “General Histology,” and “Special Histology” at Novosibirsk State University. Prokopyeva’s expertise spans virological methods, immunofluorescence, and serological diagnostics, with a focus on infectious diseases and cell biology. She has also contributed as a reviewer for MDPI and an expert for the Russian Science Foundation, reflecting her influence in the scientific community.

Research Interest

Elena Prokopyeva’s research primarily focuses on virology, particularly the study of influenza and other respiratory viruses. Her work explores the phenotypic and genotypic properties of pandemic influenza strains and their adaptation in various animal models. Prokopyeva has conducted significant research on the genetic diversity of adenoviruses and the impact of SARS-CoV-2 on respiratory infections in children. Her expertise extends to the characterization of avian and human respiratory viruses, including their interaction with host cells and susceptibility to antiviral treatments. Additionally, Prokopyeva investigates the molecular mechanisms underlying viral pathogenesis and employs advanced techniques such as immunofluorescence, real-time PCR, and electron microscopy to enhance the understanding of infectious diseases. Her contributions aim to improve diagnostic methods and therapeutic strategies for viral infections, reflecting her commitment to advancing the field of virology and infectious disease research.

Research Skills

Elena Prokopyeva possesses a diverse and advanced skill set in research, particularly within virology and infectious diseases. Her expertise includes virological methods such as virus isolation, infection assays, and the determination of virus susceptibility to inhibitors. She is adept in immunofluorescence and immunohistochemistry techniques, essential for studying viral interactions and pathogenesis. Prokopyeva’s proficiency extends to serological diagnostics using hemagglutination and microneutralization assays, as well as molecular techniques like RNA/DNA isolation, real-time PCR, and gel electrophoresis. Her experience with light and electron microscopy further enhances her capability to analyze viral structures and disease mechanisms. Prokopyeva’s role as a reviewer and expert for scientific foundations highlights her strong analytical skills and contributions to advancing the field of virology. Her comprehensive research skills, combined with her active participation in professional organizations, underscore her significant impact and ongoing commitment to her field.

Awards and Recognition

Elena Prokopyeva has earned notable recognition for her research in virology and infectious diseases. Her contributions to the field are highlighted by her role as a reviewer for the MDPI and an expert for the Russian Science Foundation, reflecting her expertise and impact on scientific research. Her work has been published in prestigious journals such as Viruses, Biochemistry (Moscow), and the Journal of Infection in Developing Countries, with high citation rates in Web of Science and Scopus. Prokopyeva’s research on influenza viruses and other pathogens has garnered significant attention, underscoring her expertise in studying viral genetic diversity and pathogenic mechanisms. Additionally, her involvement with the Euro-Asian Society for Infectious Diseases marks her as a key figure in advancing knowledge in her field. These accolades affirm her standing as a distinguished researcher and contribute to her recognition for the Best Researcher Award.

Conclusion

Elena Prokopyeva is a strong candidate for the Best Researcher Award due to her extensive research expertise, impressive publication record, and significant contributions to the field of virology. Her work in understanding and combating viral diseases, coupled with her role in educating future scientists, underscores her value as a researcher. Addressing the areas for improvement could further enhance her standing and impact in the scientific community. Overall, Prokopyeva’s achievements and ongoing contributions make her a worthy candidate for the award.

Publications Top Notes

  • “Genetic Diversity of the Human Adenovirus C Isolated from Hospitalized Children in Russia (2019–2022)”
    • Authors: Kurskaya, O.G., Prokopyeva, E.A., Dubovitskiy, N.A., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Viruses
    • Year: 2024
    • Volume: 16(3)
    • Article Number: 386
    • Citations: 1
  • “Constitutive Androstane Receptor Agonist Initiates Metabolic Activity Required for Hepatocyte Proliferation”
    • Authors: Mazin, M.E., Perevalova, A.M., Yarushkin, A.A., Gulyaeva, L.F., Pustylnyak, V.O.
    • Journal: Biochemistry (Moscow)
    • Year: 2023
    • Volume: 88(8)
    • Pages: 1061–1069
  • “Changes in the Etiology of Acute Respiratory Infections among Children in Novosibirsk, Russia, between 2019 and 2022: The Impact of the SARS-CoV-2 Virus”
    • Authors: Kurskaya, O.G., Prokopyeva, E.A., Sobolev, I.A., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Viruses
    • Year: 2023
    • Volume: 15(4)
    • Article Number: 934
    • Citations: 8
  • “Virological and Genetic Characterization of the Unusual Avian Influenza H14Nx Viruses in the Northern Asia”
    • Authors: Dubovitskiy, N., Derko, A., Sobolev, I., Shestopalov, A., Sharshov, K.
    • Journal: Viruses
    • Year: 2023
    • Volume: 15(3)
    • Article Number: 734
    • Citations: 1
  • “Virological and genetic characteristics of human respiratory syncytial viruses isolated in Russia, 2017-2018”
    • Authors: Prokopyeva, E.A., Kurskaya, O.G., Solomatina, M.V., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Journal of Infection in Developing Countries
    • Year: 2023
    • Volume: 17(2)
    • Pages: 251–259
    • Citations: 2
  • “Promotion of NR1I3-mediated liver growth is accompanied by STAT3 activation”
    • Authors: Mazin, M.E., Yarushkin, A.A., Pustylnyak, Y.A., Prokopyeva, E.A., Pustylnyak, V.O.
    • Journal: Molecular Biology Reports
    • Year: 2022
    • Volume: 49(5)
    • Pages: 4089–4093
    • Citations: 2
  • “Low incidence of human coronavirus among hospitalized children in Novosibirsk city, Russia during pre-pandemic period (2013–2020)”
    • Authors: Kurskaya, O.G., Prokopyeva, E.A., Anoshina, A.V., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Journal of Microbiology, Immunology and Infection
    • Year: 2022
    • Volume: 55(2)
    • Pages: 336–340
    • Citations: 3
  • “Anti-Influenza Activity of Medicinal Material Extracts from Qinghai–Tibet Plateau”
    • Authors: Kurskaya, O., Prokopyeva, E., Bi, H., Wei, L., Sharshov, K.
    • Journal: Viruses
    • Year: 2022
    • Volume: 14(2)
    • Article Number: 360
    • Citations: 7
  • “Etiology of influenza-like illnesses in the population of Novosibirsk City in the 2018-2019 epidemic season”
    • Authors: Kurskaya, O.G., Anoshina, A.V., Leonova, N.V., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Russian Journal of Infection and Immunity
    • Year: 2021
    • Volume: 11(4)
    • Pages: 723–736
    • Citations: 2
  • “Activation of the Akt pathway by a constitutive androstane receptor agonist results in β-catenin activation”
    • Authors: Yarushkin, A.A., Mazin, M.E., Pustylnyak, Y.A., Prokopyeva, E.A., Pustylnyak, V.O.
    • Journal: European Journal of Pharmacology
    • Year: 2020
    • Volume: 879
    • Article Number: 173135
    • Citations: 6

 

Preethinie Punyakumari Jayasekara | Immunology and Microbiology | Best Researcher Award

Posted on by ScienceFather

Mrs. Preethinie Punyakumari Jayasekara | Immunology and Microbiology | Best Researcher Award

PhD student at University of New England, Australia.

Mrs. Preethinie Punyakumari Jayasekara is a distinguished researcher with a strong background in veterinary microbiology and molecular biology. She holds a PhD from the University of Reading, an MPhil from the University of Peradeniya, and a BVSc (Hons) from the University of Sri Lanka. Her professional experience spans roles as a Veterinary Research Officer at the Veterinary Research Institute of Sri Lanka, a Government Veterinary Surgeon, and extensive research periods at notable institutions in Laos and Australia. Her research interests focus on disease diagnosis in livestock, antimicrobial resistance, and microbiological quality testing. Jayasekara has authored numerous publications, including conference proceedings and review papers. Her key skills include designing and executing research methodologies, data analysis, and collaboration with various research entities. Her work has contributed significantly to advancements in animal health and production.

Profile

Education🎓

Mrs. Preethinie Punyakumari Jayasekara holds an impressive educational background in veterinary science and microbiology. She earned her Bachelor of Veterinary Science with Honours (BVSc) from the University of Sri Lanka, where she laid the foundation for her expertise in animal health. Further advancing her knowledge, she pursued a Master of Philosophy (MPhil) in Microbiology at the University of Peradeniya, Sri Lanka, completing her degree in April 2019. Her MPhil research focused on microbiological quality testing of dairy products, specifically curd and yoghurt, aligning with SLS standards. Mrs. Jayasekara’s academic journey culminated with a Doctorate (PhD) from the University of Reading, Australia. Her doctoral studies further honed her skills in molecular biology, significantly contributing to her research capabilities and expertise in diagnosing and treating animal diseases. This robust educational background underpins her distinguished career in veterinary research and microbiology.

Professional Experience 🏢

Mrs. Preethinie Punyakumari Jayasekara has a diverse and accomplished professional background in veterinary science and microbiology. She served as a Veterinary Research Officer in the Molecular Biology Division at the Veterinary Research Institute, Sri Lanka, from July 2018 to September 2021. In this role, she was responsible for establishing molecular techniques for disease diagnosis, conducting research on animal health, and improving laboratory facilities. Her responsibilities also included data analysis, knowledge transfer, and collaboration with external institutes. Prior to this, she worked as a Government Veterinary Surgeon with the Department of Animal Production and Health, Sri Lanka, from December 2015 to July 2018. Her duties involved diagnosing and treating animal diseases, performing post-mortem examinations, and conducting mobile clinics and vaccination programs. Additionally, Mrs. Jayasekara has extensive experience in molecular biology through her work at the National Animal Health Laboratory in Laos and the Elizabeth Macarthur Agricultural Institute in Australia.

Research Interests 🔬

Mrs. Preethinie Punyakumari Jayasekara’s research interests focus on veterinary microbiology and molecular biology. Her work primarily revolves around the application of molecular techniques for disease diagnosis and animal health research. She is particularly interested in utilizing molecular methods to diagnose and manage diseases affecting livestock, such as eye infections and respiratory diseases in goats. Her research also explores the microbiological quality of dairy products and antimicrobial resistance in bacteria from dairy cattle and the farm environment. Mrs. Jayasekara’s expertise includes nucleic acid extraction, PCR assays, and phylogenetic analysis, which she applies to improve animal health and production. She has contributed to the understanding of disease constraints in goat production and has been involved in diagnosing and addressing various animal health issues through advanced microbiological techniques.

Award and Honors

Mrs. Preethinie Punyakumari Jayasekara has earned recognition for her significant contributions to veterinary microbiology and molecular biology. Her work, particularly in diagnosing animal diseases and improving animal health, has been highlighted in various scientific conferences. Notably, she presented at the 9th International Conference on Sustainable Animal Agriculture for Developing Countries (SAADC2023), where she discussed topics such as the causation of pinkeye in Lao goats and the impact of diseases on goat production in Lao PDR. Her research has also been acknowledged in several proceedings and scientific journals. Additionally, she has been instrumental in advancing veterinary research through her role at the Veterinary Research Institute in Sri Lanka, where she established techniques for disease diagnosis and contributed to knowledge transfer programs. Her achievements underscore her dedication to improving animal health and advancing veterinary science.

Research Skills

Mrs. Preethinie Punyakumari Jayasekara possesses extensive research skills, primarily in veterinary microbiology and molecular biology. Her expertise includes sample collection, research planning, and methodology development. She is skilled in designing and selecting primers and probes, performing nucleic acid extraction, and conducting PCR assays. Her proficiency extends to data analysis using tools such as MS Excel, RStudio, Geneious Prime, and Mega10. Jayasekara has practical experience with agarose gel electrophoresis, PCR product purification, and phylogenesis. Additionally, she has demonstrated her ability to diagnose animal diseases and develop research techniques at institutions like the National Animal Health Laboratory in Laos and the Elizabeth Macarthur Agricultural Institute in Australia. Her work also involves collaboration with other research divisions and external organizations, contributing to knowledge transfer and advancing research in animal health and production.

Publications Top Notes 📚